Company Overview

PRIME exits® and American Healthcare Capital proudly and exclusively represent this opportunity. Project Beacon is a scaled, pre-paid, payer-embedded value-based care platform that helps health plans manage complex Medicare Advantage and Medicaid members.

In simple terms, the Company helps plans find high-risk members earlier, stay engaged over time, and steer care to lower-cost settings before medical problems become more serious or more expensive.

The model combines recurring per-member-per-month management fees with performance-based upside tied to cost, quality, and documentation improvement.

Business Model

1. Find risk early

Use real-time data, predictive models, and local care teams to identify members before acute events occur.

2. Stay engaged longer

Maintain longitudinal relationships through field-based and virtual care coordination, follow-up, and transitions of care.

3. Improve plan economics

Reduce avoidable hospital use, improve documentation of illness burden, close quality gaps, and support better medical loss ratio performance.

Why health plans buy the model •Embedded inside payer workflows rather than sold as a detached point solution.

• Recurring PMPM fee base with additional upside from performance, quality, and coding improvement.

• Attribution-agnostic approach designed to serve broader Medicare Advantage and Medicaid populations, including PPO members.

• Clinical model built to improve cost performance, documentation, quality metrics, and medical loss ratio.

Why the opportunity stands out

• Scaled platform with 100k+ managed lives and a path from 7 contracts in 2026 to 10 contracts by 2030.

• Proprietary data and AI platform ingests 500+ feeds and supports earlier risk identification, care coordination, reporting, and quality management.

• 2026 is a reset year after contract rebasing and portfolio clean-up, creating a cleaner go-forward base.

• Embedded partner expansion, a >$90mm unweighted new-business pipeline, and specialty / platform adjacencies provide multiple growth paths.

Projected financial profile

Management presents 2026 as a rebased year, with re-acceleration expected from 2027 onward.

Important: total revenue includes significant risk revenue; investors

must focus heavily on recurring management fee revenue and normalized

EBITDA.

Growth drivers

Expansion inside existing payer relationships, including a major national Medicare Advantage partner.

• Growth from 7 contracts in 2026 to 10 by 2030, with managed lives increasing to roughly 338k.

• More than $90mm of unweighted annual management fee revenue in the current pipeline.

• Specialty and technology-enabled adjacencies may broaden revenue sources over time.

Risk reset and diligence focus

•  Legacy exposure is presented as reduced, largely isolated, and mostly structured, bounded, or timing driven.

• Remaining hard exposure is described at roughly $25mm, primarily one structured settlement under $10mm and one timing-driven deficit of about $15mm.

• Planned capital is intended mainly for settlements, debt refinancing, working capital, and growth - not for ongoing operating losses.

• Key diligence areas include customer concentration, durability of post-reset contract economics, and confirmation that reserve / reinsurance plans are sufficient.

Valuation guidance and deal structure

Valuation will be determined through discussion, diligence, and negotiation, with emphasis on normalized go-forward management fee revenue, forward adjusted EBITDA, the quality of embedded payer relationships, platform scalability, and visible growth opportunities.

Leadership is open to value-maximizing structures, including a majority recapitalization or majority sale, a strategic growth investment, and performance-based elements such as rollover equity and earn-out components where appropriate.